1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cardiovascular Stroke in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (18.42) | 18.7374 |
| 1990's | 20 (52.63) | 18.2507 |
| 2000's | 7 (18.42) | 29.6817 |
| 2010's | 3 (7.89) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Gai, JX; Huang, MQ; Ji, WH; Li, LL; Li, TY; Li, XL; Liang, HH; Lv, X; Shan, HL; Song, XY; Su, W; Yang, N; Zhang, J; Zhang, Q; Zhao, XG; Zhou, YH | 1 |
| Ahmed, S; Dima, L; Gul, S; Moga, M; Ze Jaafar, H; Zia-Ul-Haq, M | 1 |
| Chen, ZQ; Hong, L; Wang, H; Yin, QL | 1 |
| Alloatti, G; Gattullo, D; Mancardi, D; Mognetti, B; Moro, F; Pagliaro, P; Penna, C; Tullio, F | 1 |
| Dong, CM; Jia, XQ; Qin, J; Zhang, L | 1 |
| Bergerone, S; Camussi, G; Del Sorbo, L; Emanuelli, G; Lupia, E; Montrucchio, G | 1 |
| Buchanan, MR | 1 |
| Jin, Y; Qin, G; Wang, J; Yu, L; Zhang, J; Zhang, S | 1 |
| Alloatti, G; Gattullo, D; Mancardi, D; Mognetti, B; Pagliaro, P; Penna, C; Tullio, F | 1 |
| Dye, JF; Egdell, RM; O'Gorman, DJ; Sheridan, DJ; Siminiak, T | 1 |
| Eccleston, DS; Graham, RM; Strahan, ME; Sturm, MJ; Taylor, RR | 1 |
| Davies, BH; Gray, M; Hughes, KT; Jones, KP; Reynolds, SP; Rolf, S | 1 |
| Graham, RM; Norman, KW; Strahan, ME; Sturm, MJ; Taylor, RR; Watkins, DN | 1 |
| Chopra, K; Ganguly, NK; Gupta, S; Singh, M | 1 |
| Graham, RM; Richardson, M; Stephens, CJ; Sturm, MJ; Taylor, RR | 1 |
| Alloatti, G; Bergerone, S; Bussolino, F; Camussi, G; Cravetto, A; Di Leo, M; Emanuelli, G; Lupia, E; Montrucchio, G; Silvestro, L | 1 |
| Alloatti, G; Cacace, G; Camussi, G; Comino, A; De Filippi, PG; Emanuelli, G; Mariano, F; Montrucchio, G; Polloni, R | 1 |
| Ansley, DM; English, JC; Godin, DV; Kim, CW; Lee, JU; Loucks, EB; Qayumi, AK | 1 |
| Gurbel, PA; Lowry, DR; Murugesan, SR; Serebruany, VL; Sturm, E; Svetlov, SI | 1 |
| Auchampach, JA; Cavero, I; Gross, GJ; Pieper, GM | 1 |
| Daikoku, S; Goto, Y; Itoh, A; Matsumoto, T; Miyao, Y; Miyazaki, S; Morii, I; Nonogi, H | 1 |
| Fukuda, N; Ito, S; Soeki, T; Tamura, Y | 1 |
| Curtis, L; Fatovich, D; Hitchcock, T; Morrison, C; Taylor, R | 1 |
| Black, SC; Driscoll, EM; Lucchesi, BR | 1 |
| Inada, M; Iwasaka, T; Sugiura, T; Takayama, Y; Taniguchi, H | 1 |
| Chakrabarty, S; Flores, NA; Fluck, DS; Sheridan, DJ | 1 |
| Leong, LL; Stephens, CJ; Sturm, MJ; Taylor, RR | 1 |
| Berti, F; De Angelis, L; Galli, G; Magni, F; Rossoni, G | 1 |
| Donas, A; Droudes, C; Evangelou, A; Tselepis, AD; Tsoukatos, D | 1 |
| Chakrabarty, S; Sheridan, DJ; Thomas, P | 1 |
| Alloatti, G; Camussi, G; Comino, A; de Paulis, R; Emanuelli, G; Mariano, F; Montrucchio, G | 1 |
| Kendrew, PJ; Nidorf, SM; Strophair, J; Sturm, M; Taylor, RR | 1 |
| Lucchesi, BR; Mickelson, JK; Simpson, PJ | 1 |
| Holtz, H; Lang, A; Ostermann, G; Rühling, K; Till, U; Winkler, L | 1 |
| Bugriĭ, EM; Karpov, IuA; Kiktev, VG; Kuz'min, AV; Men'shikov, MIu | 1 |
| Hansen, BF; Hansen, JF | 1 |
| Peskar, BA; Simmet, T | 1 |
| Gratsianskiĭ, NA; Men'shikov, MIu; Panchenko, EP; Shalaev, SV; Tkachuk, VA | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiovascular Stroke
| Article | Year |
|---|---|
[Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology].
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Calcium Channel Blockers; Coronary Angiography; Coronary Vessels; Death, Sudden; Endoscopy; Heparin; Humans; Myocardial Infarction; Platelet Activating Factor | 1987 |
Eicosanoids and the coronary circulation.
Topics: Anaphylaxis; Animals; Coronary Circulation; Coronary Disease; Epoprostenol; Fatty Acids, Unsaturated; Humans; Myocardial Infarction; Platelet Activating Factor; Thromboxanes | 1986 |
4 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiovascular Stroke
| Article | Year |
|---|---|
[Effects of Tongxinluo Capsule on Platelet Activating Factor, Vascular Endothelial Function, Blood Flow of Thrombolysis in Myocardial Infarction in Acute Myocardial Infarction Patients after Delayed Percutaneous Coronary Intervention].
Topics: Angioplasty, Balloon, Coronary; Blood Pressure; Drugs, Chinese Herbal; Endothelium, Vascular; Fibrinolytic Agents; Heart; Heart Rate; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Activating Factor; Regional Blood Flow; von Willebrand Factor | 2016 |
[Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coronary Disease; Double-Blind Method; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Prospective Studies; Ticlopidine; Tissue Plasminogen Activator; von Willebrand Factor | 2012 |
Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Biomarkers; Electrocardiography; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Platelet Activating Factor; Severity of Illness Index; Thrombolytic Therapy | 1998 |
Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction.
Topics: Aged; Creatine Kinase; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypotension; Imidazoles; Leucine; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Streptokinase; Thrombolytic Therapy | 2001 |
32 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiovascular Stroke
| Article | Year |
|---|---|
Critical role of PAFR/YAP1 positive feedback loop in cardiac fibrosis.
Topics: Animals; Feedback; Fibroblasts; Fibrosis; Mice; Mice, Transgenic; Myocardial Infarction; Platelet Activating Factor; Signal Transduction | 2022 |
Anti-platelet effects of nimesulide in isoproterenol-induced myocardial ischaemia and infarction in rabbits.
Topics: Animals; Disease Models, Animal; Isoproterenol; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Rabbits; Sulfonamides; Sympathomimetics; Treatment Outcome | 2015 |
Post-ischaemic activation of kinases in the pre-conditioning-like cardioprotective effect of the platelet-activating factor.
Topics: Animals; Blotting, Western; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Ischemic Preconditioning, Myocardial; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Organ Culture Techniques; Platelet Activating Factor; Protein Kinases; Rats; Rats, Wistar | 2009 |
The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils.
Topics: Cells, Cultured; Complement Activation; Complement Membrane Attack Complex; Endothelium; Epitopes; Female; Fibrinolysin; Fibrinolysis; Fluorescent Antibody Technique, Direct; Humans; Male; Middle Aged; Myocardial Infarction; Neutrophils; Platelet Activating Factor; Streptokinase | 2003 |
Biological basis and clinical implications of acetylsalicylic acid resistance.
Topics: Acetylation; Acetyltransferases; Arachidonic Acid; Aspirin; Drug Resistance; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Stroke; Thromboxane A2 | 2006 |
Elevated levels of platelet-monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome.
Topics: Aged; Analysis of Variance; Biomarkers; C-Reactive Protein; CD40 Ligand; Coronary Angiography; Cross-Sectional Studies; Female; Humans; Interleukin-6; Interleukin-8; Logistic Models; Male; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Activating Factor; Probability; Prognosis; Reference Values; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric | 2007 |
The platelet activating factor triggers preconditioning-like cardioprotective effect via mitochondrial K-ATP channels and redox-sensible signaling.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidation-Reduction; Platelet Activating Factor; Potassium Channels; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction | 2008 |
Plasma-mediated neutrophil activation during acute myocardial infarction: role of platelet-activating factor.
Topics: Aged; CD18 Antigens; Cells, Cultured; Female; Humans; L-Selectin; Macrophage-1 Antigen; Male; Middle Aged; Myocardial Infarction; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Superoxides | 1995 |
Neutrophil platelet-activating factor production and acetyltransferase activity in clinical acute myocardial infarction.
Topics: Acetyltransferases; Aged; Cell Count; Humans; Male; Middle Aged; Myocardial Infarction; Neutrophils; Platelet Activating Factor; Time Factors | 1995 |
Salivary PAF in acute myocardial infarction and angina: changes during hospital treatment and relationship to cardiac enzymes.
Topics: Angina Pectoris; Asthma; Creatine Kinase; Enzyme-Linked Immunosorbent Assay; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Activating Factor; Radioimmunoassay; Receptors, Interleukin-2; Saliva; Tuberculosis, Pulmonary | 1994 |
Platelet and plasma platelet-activating factor in sepsis and myocardial infarction.
Topics: Adult; Aged; Bacterial Infections; Blood Platelets; Humans; Male; Middle Aged; Myocardial Infarction; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1994 |
Involvement of oxygen free radicals in the action of BN 52021 (PAF antagonist) to limit myocardial infarct size.
Topics: Analysis of Variance; Animals; Blood Pressure; Diterpenes; Electrocardiography; Female; Free Radicals; Ginkgolides; Glutathione Peroxidase; Heart Ventricles; Lactones; Luminescent Measurements; Male; Malondialdehyde; Myocardial Infarction; Myocardium; Neutrophils; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1993 |
Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Cholesterol; Half-Life; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Platelet Activating Factor | 1993 |
Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells.
Topics: Cells, Cultured; Endothelium, Vascular; Female; Fibrinolysin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Stimulation, Chemical; Streptokinase; Time Factors; Tissue Plasminogen Activator | 1993 |
Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart.
Topics: Animals; Azepines; Cell Movement; Female; Heart; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Platelet Activating Factor; Quinolines; Rabbits; Risk Factors; Triazoles | 1993 |
The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury.
Topics: Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Blood Pressure; Cardiac Output; Cardiac Volume; Disease Models, Animal; Female; Heart Arrest; Hemodynamics; Isoquinolines; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Random Allocation; Stroke Volume; Swine; Tetrahydroisoquinolines; Ventricular Fibrillation; Ventricular Function | 1998 |
Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
Topics: Animals; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Free Radicals; Incidence; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Neutrophils; Peroxidase; Platelet Activating Factor; Pyridines; Reperfusion Injury; Thiazoles; Ventricular Fibrillation | 1998 |
Role of cytokines and adhesion molecules in ischemia and reperfusion in patients with acute myocardial infarction.
Topics: Acute Disease; Cell Adhesion Molecules; Humans; Interleukin-6; Myocardial Infarction; Myocardial Reperfusion Injury; Platelet Activating Factor | 1999 |
Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Topics: Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; beta-Thromboglobulin; Biomarkers; Blood Coagulation Factors; Blood Platelets; Cohort Studies; Coronary Disease; Female; Fibrinolysin; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Platelet Activating Factor; Platelet Factor 4; Time Factors; Tissue Plasminogen Activator | 2000 |
Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage.
Topics: Animals; Azepines; Blood Pressure; Coronary Circulation; Dogs; Heart Rate; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Platelet Aggregation; Triazoles | 1992 |
Role of platelet-activating factor in pulmonary edema after coronary ligation in dogs.
Topics: Animals; Coronary Circulation; Coronary Vessels; Dogs; Extravascular Lung Water; Hemodynamics; Ligation; Myocardial Infarction; Platelet Activating Factor; Pulmonary Edema; Pyridinium Compounds | 1992 |
Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Blood Pressure; Electrocardiography; Heart Rate; Hemodynamics; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Platelet Activating Factor; Rabbits; Thienopyridines; Triazoles | 1992 |
Effect of WEB 2086 on myocardial infarct size and regional blood flow in the dog.
Topics: Animals; Azepines; Cardiac Output; Coronary Disease; Disease Models, Animal; Dogs; Myocardial Infarction; Myocardium; Platelet Activating Factor; Regional Blood Flow; Triazoles | 1992 |
Production and biologic interactions of prostacyclin and platelet-activating factor in acute myocardial ischemia in the perfused rabbit heart.
Topics: Animals; Epoprostenol; In Vitro Techniques; Indomethacin; Male; Myocardial Infarction; Myocardium; Perfusion; Platelet Activating Factor; Polydeoxyribonucleotides; Rabbits | 1990 |
Platelet response to the aggregatory effect of platelet activating factor (PAF) ex vivo in patients with acute myocardial infarction.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Drug Resistance; Epoprostenol; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Time Factors | 1991 |
Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia.
Topics: Animals; Arrhythmias, Cardiac; Blood Platelets; Diterpenes; Ginkgolides; Hypotension; Imidazoles; Immune Sera; Lactones; Myocardial Infarction; Necrosis; Platelet Activating Factor; Platelet Activation; Pyridines; Rabbits; Thromboxane A2; Thromboxane-A Synthase | 1991 |
Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart.
Topics: Animals; Collateral Circulation; Coronary Circulation; Female; Indium Radioisotopes; Leukocyte Count; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Platelet Activating Factor; Platelet Count; Rabbits | 1990 |
Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina.
Topics: Adenosine Diphosphate; Aged; Angina Pectoris; Angina, Unstable; Collagen; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Thromboxane B2 | 1989 |
Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart.
Topics: Animals; Coronary Vessels; Heart; Male; Myocardial Infarction; Myocardium; Perfusion; Platelet Activating Factor; Rabbits; Vasoconstriction; Vasoconstrictor Agents | 1988 |
The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients.
Topics: Apolipoproteins; Arteriosclerosis; Biomarkers; Humans; Lipids; Male; Myocardial Infarction; Platelet Activating Factor; Platelet Function Tests; Predictive Value of Tests | 1988 |
[Calcium metabolism of the thrombocytes in ischemic heart disease].
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Blood Platelets; Calcium; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Time Factors | 1988 |
[Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
Topics: Adenosine Diphosphate; Adult; Angina Pectoris; Blood Platelets; Calcium; Coronary Artery Disease; Coronary Disease; Cytoplasm; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Platelet Activating Factor; Platelet Aggregation; Serotonin | 1986 |